Gary J. Stephens

Reading, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 53 publications

Emerging therapeutic opportunities for psychedelic and related drugs.

Emerging therapeutic opportunities for psychedelic and related drugs.

Journal: British journal of pharmacology

Published: May 25, 2026

Psilocybin ameliorates neuropathic pain-like behaviour in mice and facilitates gabapentin-mediated analgesia.

Psilocybin ameliorates neuropathic pain-like behaviour in mice and facilitates gabapentin-mediated analgesia.

Journal: Communications biology

Published: March 10, 2026

Updated BJP guidelines for transparent and rigorous natural product research.

Updated BJP guidelines for transparent and rigorous natural product research.

Journal: British journal of pharmacology

Published: February 09, 2026

Novel drugs approved by the EMA, the FDA and the MHRA in 2025: A year in review.

Novel drugs approved by the EMA, the FDA and the MHRA in 2025: A year in review.

Journal: British journal of pharmacology

Published: January 16, 2026

Reporting innovations in pharmacology and drug development, upholding excellence and improving author experience at the British Journal of Pharmacology in 2024.

Reporting innovations in pharmacology and drug development, upholding excellence and improving author experience at the British Journal of Pharmacology in 2024.

Journal: British journal of pharmacology

Published: May 19, 2025

Guidance on the planning and reporting of experimental design and analysis.

Guidance on the planning and reporting of experimental design and analysis.

Journal: British journal of pharmacology

Published: January 27, 2025

Novel drugs approved by the EMA, the FDA and the MHRA in 2024: A year in review.

Novel drugs approved by the EMA, the FDA and the MHRA in 2024: A year in review.

Journal: British journal of pharmacology

Published: January 03, 2025

Peptide-Purified Anti-N-methyl-D-aspartate Receptor (NMDAR) Autoantibodies Have Inhibitory Effect on Long-Term Synaptic Plasticity.

Peptide-Purified Anti-N-methyl-D-aspartate Receptor (NMDAR) Autoantibodies Have Inhibitory Effect on Long-Term Synaptic Plasticity.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: September 05, 2024

Psilocybin as a novel treatment for chronic pain.

Psilocybin as a novel treatment for chronic pain.

Journal: British journal of pharmacology

Published: August 24, 2024

Natural product pharmacology: the British Journal of Pharmacology perspective.

Natural product pharmacology: the British Journal of Pharmacology perspective.

Journal: British journal of pharmacology

Published: June 14, 2024

Novel drugs approved by the EMA, the FDA, and the MHRA in 2023: A year in review.

Novel drugs approved by the EMA, the FDA, and the MHRA in 2023: A year in review.

Journal: British journal of pharmacology

Published: January 27, 2024

From Llama to Nanobody: A Streamlined Workflow for the Generation of Functionalised VHHs.

From Llama to Nanobody: A Streamlined Workflow for the Generation of Functionalised VHHs.

Journal: Bio-protocol

Published: December 20, 2023

Showing 1-12 of 53

Last Updated: 09/26/2026